Introduction
Oncogenes were originally discovered as single oncogenic determinants in the genomes of highly oncogenic retroviruses. The subsequent discovery of multiple oncogenes in single retroviral genomes, acquired by multiple transductions of cellular proto-oncogenes, provided strong genetic and molecular evidence in support of the notion that oncogenes cooperate in cell transformation and that multiple mutational events enhance tumorigenesis. One of the viruses containing more than one oncogene, avian leukaemia-and carcinoma-inducing retrovirus MH2, carries transduced v-myc and v-mil alleles derived from the cellular protooncogenes c-myc and c-mil, respectively (Jansen et al., 1983a (Jansen et al., , b, 1984 Bister and Jansen, 1986) . The myc oncogene, originally identified as a single oncogenic determinant (v-myc) in avian acute leukemia virus MC29, encodes a bHLHZip protein (Myc), encompassing protein dimerization (helix-loop-helix, leucine zipper) and DNA contact (basic region) surfaces, that forms heterodimers with the Max protein and binds to specific DNA sequence elements (E-boxes) Duesberg et al., 1977; Blackwell et al., 1990; Blackwood and Eisenman, 1991; Kerkhoff et al., 1991; Dang, 1999; Grandori et al., 2000; Eisenman, 2001) . The Myc-Max transcription factor complex is a key regulator of genes critically involved in cellular growth, proliferation, metabolism, and differentiation (Blackwood and Eisenman, 1991; Dang, 1999; Grandori et al., 2000; Eisenman, 2001) .
The v-mil oncogene identified in MH2 (Jansen et al., 1983a, b) is the avian ortholog of the mammalian v-raf oncogene Sutrave et al., 1984) that was independently defined as a single oncogenic determinant in murine retrovirus 3611-MSV (Rapp et al., 1983) . The c-mil(raf) proto-oncogene encodes the serine/threonine-specific protein kinase c-Mil(Raf) that is an important part of a conserved signalling pathway transducing signals from the cell surface to the nucleus (Bister and Jansen, 1986; Wellbrock et al., 2004) . Growth factor binding to cell surface receptors leads to activation of Ras and subsequently of Mil(Raf). Mil(Raf) then activates the dual-specificity protein kinases MEK1 and MEK2 which in turn activate mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) (Eferl and Wagner, 2003; Wellbrock et al., 2004) . The concomitant expression of the v-myc and v-mil(raf) oncogenes by the natural retroviral isolate MH2 and by the highly oncogenic recombinant murine retrovirus J2 (Rapp et al., 1985) correlates with the strongly enhanced oncogenic potential of these viruses including very rapid induction of hematopoietic neoplasms and liver tumors (Rapp et al., 1985; Graf et al., 1986 ).
An important nuclear effector in the ERK signaling pathway is the activator protein-1 (AP-1) transcription factor complex (Rapp et al., 1994; Suzuki et al., 1994; Shaulian and Karin, 2002; Eferl and Wagner, 2003) converting cytosolic signals into changes of gene expression programs. AP-1 represents a heterogeneous collection of dimers composed of members of the Jun, Fos, or activating transcription factor (ATF) protein families, and is a key regulator of genes involved in cell proliferation or differentiation (Curran and Franza, 1988; Ransone and Verma, 1990; Vogt and Bos, 1990; Shaulian and Karin, 2002; Vogt, 2002; Eferl and Wagner, 2003) . Jun proteins can bind to DNA as functional homodimers, whereas Fos proteins need a member of the Jun protein family for dimerization (Curran and Franza, 1988; Ransone and Verma, 1990; Vogt and Bos, 1990; Vogt, 2002) . AP-1 transcription factors bind with high affinity to the 12-O-tetradecanoyl-phorbol-13-acetate responsive element (TRE) with the consensus sequence 5 0 -TGA C / G TCA-3 0 , or to variants thereof, in the promoters of various target genes (Curran and Franza, 1988; Vogt and Bos, 1990; Vogt, 2002) . The oncogenic v-jun or v-fos alleles were generated by retroviral transduction of the cellular c-jun or c-fos proto-oncogenes (Curran and Franza, 1988; Vogt and Bos, 1990) .
To elucidate the molecular mechanisms of synergistic Myc/Mil(Raf) oncogenic signaling, we searched for specific genes differentially expressed in v-myc/v-mil (raf)-transformed avian cells. Here we report on the identification and functional characterization of three strongly activated genes: osteopontin (OPN) (Denhardt et al., 2001) , 126MRP, related to the S100 gene family (Marenholz et al., 2004) , and rac2, a member of the Rho gene family encoding small GTPases (Didsbury et al., 1989; Jaffe and Hall, 2005) . Intriguingly, OPN and members of the S100 and Rho gene families have been implicated in molecular processes linked to cell migration, invasion, and metastasis (Marenholz et al., 2004; Rittling and Chambers, 2004; Kurisu et al., 2005) . We show that transcriptional activation of OPN, a typical marker gene for metastatic tumor cells (Denhardt et al., 2001; Weber, 2001; Moye et al., 2004; Rittling and Chambers, 2004) , is dependent on cFos which is highly expressed in v-myc/v-mil(raf)-transformed cells. Furthermore, ectopic expression of OPN, 126MRP, or Rac2 proteins from a retroviral vector causes partial transformation of primary avian fibroblasts, suggesting that these gene products are critically involved in oncogenesis induced by Myc/ Mil(Raf), possibly in a joint signaling pathway. Our data also suggest that AP-1 plays an important role in vmyc/v-mil(raf)-induced oncogenesis, and that concerted action of the oncogenic transcription factor complexes Myc-Max and Jun-Fos contributes to full neoplastic transformation.
Results
AP-1 activation and differential gene expression in v-myc/ v-mil-transformed fibroblasts Avian fibroblasts transformed by concomitant expression of the v-myc and v-mil oncogenes of avian acute leukemia virus MH2 display a fully transformed phenotype, manifested by rapid growth and extensive morphological changes of cells in culture and by a very high potential of rapid anchorage-independent growth. In these parameters, they surpass cells transformed by a single oncogene, like the v-myc oncogene of avian acute leukemia virus MC29, or the v-mil or v-jun oncogene, carried by retroviral constructs (Figure 1a and b). To elucidate the molecular mechanisms underlying the high oncogenic potential of MH2 both in vitro and in vivo (Rapp et al., 1985; Bister and Jansen, 1986; Graf et al., 1986) , we used comparative gene expression analyses to identify genes specifically activated in v-myc/v-miltransformed quail embryo fibroblasts.
To confirm oncoprotein expression in the cells used for comparison (Figure 1a and b) , immunoprecipitation analysis of [ 35 S]methionine-labeled proteins from cellular extracts was carried out using antibodies raised against Myc and Mil, or against the AP-1 components Jun and Fos (Figure 1c ). In the MC29-transformed quail embryo fibroblast (QEF) line Q8, v-myc is expressed as a 110-kDa Gag-Myc hybrid protein , and in the MH2-transformed QEF line MH2A10, v-mil is expressed as a 100-kDa Gag-Mil hybrid protein (Jansen et al., 1983a) . The v-Myc protein in MH2A10 cells, the v-Mil protein in QEF transformed by retroviral construct RCAS-v-Mil, and the v-Jun protein in RCASv-Jun-transformed QEF are devoid of Gag sequences. In accordance with previous observations (Patschinsky and Bister, 1988; Hartl and Bister, 1998) , the cellular proto-oncoproteins c-Myc or c-Jun were not detectable in Q8, MH2A10, or QEF/RCAS-v-Jun cells, respectively, which contain high levels of the corresponding viral oncoproteins v-Myc or v-Jun, whereas expression of c-Mil was observed at low levels in all cell types tested. Interestingly, expression levels of c-Jun and c-Fos were elevated in v-myc-transformed and particularly in v-myc/v-mil-transformed cells (Figure 1c ), suggesting that cell transformation induced by MH2 may involve activation of AP-1. In contrast, normal QEF, or cells transformed by v-mil (QEF/RCAS-v-Mil) or v-jun (QEF/RCAS-v-Jun), did not contain detectable amounts of the 62-kDa c-Fos protein (Figure 1c) . The Fos-specific antiserum raised against a recombinant GST-Fos hybrid protein also detected a 67-kDa nonspecific protein band in all cell types as described previously .
Based on the observation of significantly elevated c-Fos and c-Jun protein levels in v-myc/v-mil-transformed cells, we were interested in the identification of genes that are differentially expressed in these cells and possibly regulated by AP-1. Using mRNA preparations from MH2A10 cells and from normal QEF, subtractive hybridization technologies led to the identification of three genes that were expressed at high levels in the v-myc/v-mil-transformed MH2A10 cells, compared to and MH2A10 (Jansen et al., 1983a, b) transformed by MC29 (v-myc) or MH2 (v-myc and v-mil), respectively, and of QEF transfected with retroviral constructs carrying the coding regions of v-mil (pRCAS-v-Mil) Proteins were analysed by immunoprecipitation using polyclonal rabbit antisera (a) directed against the indicated recombinant proteins, and precipitated proteins were resolved by SDS-PAGE (10%, wt/vol). Fluorographs were exposed for 4 d (a-Myc, a-Mil, a-Jun) or 6 d (a-Fos). The positions of molecular weight markers (in kDa) are indicated in the margin. (d) Differential expression of genes specifying osteopontin (OPN), the S100-related calcium binding protein (126MRP), or the Rho-family protein Rac2 (rac2) in vmyc/v-mil-transformed fibroblasts, monitored by Northern analyses using 2.5-mg aliquots of poly(A) þ -selected RNAs from the cells shown in panel a. Filters were hybridized with 32 P-labeled cDNA probes specific for OPN (0.9 Â 10 6 cpm/ml, 6-h exposure), 126MRP (0.8 Â 10 6 cpm/ml, 6-h exposure), rac2 (1.3 Â 10 6 cpm/ml, 240-h exposure), or GAPDH (0.8 Â 10 6 cpm/ml, 20-h exposure). The positions of ribosomal RNAs on the filter shown in full size (OPN) are indicated in the margin. Autoradiography was done using an intensifying screen. The sizes of the mRNAs are 1.4 kb (OPN), 0.8 kb (126MRP), 1.2 kb (rac2), and 1.4 kb (GAPDH). low or undetectable levels of expression in normal QEF or in cells transformed by v-mil or v-jun (Figure 1d) . Expression of these genes was also slightly enhanced in the v-myc-transformed cell line Q8 (Figure 1d ). Nucleotide sequence analyses of the isolated clones showed that the corresponding mRNAs encode quail homologs of proteins specified by the chicken genes osteopontin (OPN) (Castagnola et al., 1991) , 126MRP (Nakano and Graf, 1992) , or by the human rac2 gene (Didsbury et al., 1989) .
The deduced amino-acid sequences of the quail proteins were compared with those of their orthologs from chicken and man (Figure 2 ). Human homologs of OPN and Rac2 could be clearly defined. In the case of 126MRP, originally identified as the protein product of chicken clone MRP-126 (Nakano and Graf, 1992) , sequence similarities with multiple human proteins were found, all belonging to the small calcium-binding protein family S100 (Donato, 1999; Marenholz et al., 2004) . Of these, the S100A9 protein, also known as calgranulin B or migration inhibitory factor-related protein 14 , displays the closest relationship to quail or chicken 126MRP. In the compared sequences, functional protein domains are well conserved, including signal and cell adhesion sequences in OPN, EF hands in 126MRP/S100A9, and the GTPase domain in Rac2 (Figure 2 ). The quail and chicken orthologs share a high degree of identity at the aminoacid and nucleotide-sequence levels. Compared to their human orthologs, sequences outside the functional domains of avian osteopontin or 126MRP are less conserved. In contrast, human Rac2 displays a high degree of sequence similarity with its avian homologs throughout the entire protein sequences (Figure 2 ).
Mechanism of OPN activation in v-myc/v-miltransformed fibroblasts
The cytokine OPN identified here as a putative target of v-myc/v-mil signaling has been implicated in cell transformation and metastasis, and is regarded as a candidate target for cancer therapy (Weber, 2001; Moye et al., 2004; Rittling and Chambers, 2004) . Hence, we decided to study the regulation of the avian OPN gene Figure 1d ), primary chicken embryo fibroblasts (CEF) were freshly transformed by the MH2 virus (CEF/MH2) and passaged. mRNA was isolated from these cells and analysed by Northern hybridization in comparison with mRNAs from normal CEF and from CEF transformed by the ASV17 virus carrying the v-jun oncogene (Vogt and Bos, 1990) . Furthermore, secreted OPN protein (p52 OPN ) levels were analysed by immunoprecipitation using an antiserum directed against OPN recombinant protein (see below). The analysis showed that the OPN gene is specifically and efficiently activated at the mRNA and protein level in CEF transformed by the MH2 virus (Figure 3a) .
The chicken OPN promoter was cloned and inserted into a chloramphenicol acetyltransferase (CAT) reporter plasmid yielding the pCAT-OPN construct. Transient transfection of the pCAT-OPN plasmid into the established cell line MH2A10 and subsequent CAT Figure 3 Transactivation of the osteopontin promoter. (a) Left panel: Northern analysis using 30-mg aliquots of total RNAs from chicken embryo fibroblasts (CEF), and from CEF transformed by the retroviruses ASV17 or MH2 carrying the v-jun or v-myc/v-mil oncogenes, respectively. Filters were hybridized with 32 P-labeled cDNA probes specific for OPN (1.0 Â 10 6 cpm/ml, 22-h exposure) and GAPDH (1.2 Â 10 6 cpm/ml, 20-h exposure). Autoradiography was done using an intensifying screen. The sizes of the mRNAs are 1.4 kb (OPN) and 1.4 kb (GAPDH). In addition to the 1.4-kb OPN mRNA also observed in MH2-transformed QEF (cf. Figure 1d analysis revealed that the OPN promoter becomes strongly activated in these cells (Figure 3b ). No or moderate promoter activities were seen in v-jun-transformed cells or in normal QEF in correlation with no or low mRNA expression in these cells, respectively (cf. Figure 1d ). The basal activation of the OPN promoter in normal QEF may be due to endogenous AP-1 components like c-Jun or JunD (see below) which are absent in v-jun-transformed cells (cf. Figure 1c and data not shown). Bioinformatic analysis of the chicken OPN promoter region revealed the presence of three potential non-consensus AP-1 binding sites (5 0 -TGA CTCC-3 0 , 5 0 -CCTCATGAC-3 0 and 5 0 -TGACCTCA-3 0 ) which have recently been described as functional binding sites located in the promoters of the monocyte chemotactic protein 1 or mouse osteopontin genes (Shyy et al., 1995; Bidder et al., 2002) , or in the bovine leukemia virus genome (Merezak et al., 2001) , respectively. The latter two sequence motifs overlap in the chicken OPN promoter giving rise to a 5 0 -CCTCATG ACCTCA-3 0 sequence element termed here the proximal AP-1 binding motif (Figure 3c ). Site-directed mutagenesis leading to deletion of the distal or disruption of the proximal AP-1 binding motifs in pCAT-OPN showed that only mutation of the proximal AP-1 binding motif led to significant reduction in CAT-activity (Figure 3c ). Progressive 5 0 -deletion analysis of pCAT-OPN demonstrated that a 96-bp region (pCAT-OPN96) containing the critical proximal AP-1 motif and a TATA box was sufficient to confer almost full promoter activity (Figure 3c ). The enhancer and basal promoter motifs are located at nucleotide positions À89 to À77 and À30 to À24, respectively. No potential binding sites for the Myc/Max transcription factor complex were found in this minimal promoter segment. Deletion of the proximal AP-1 binding motif, of the TATA box, or of both sites, led to a drastic reduction of CAT activity (Figure 3c ) indicating that these binding sites are required as essential promoter elements for activation of the OPN gene in v-myc/v-mil-transformed cells. To test directly if AP-1 components are necessary for transcriptional activation, the promoter construct pCAT-OPN96 was co-transfected with eukaryotic expression vectors specifying v-Myc, v-Jun, c-Jun, c-Fos, or the Jun-and Fos-related proteins JunD and Fra-2, respectively, into normal QEF (Figure 3d ). The analysis revealed that high-level expression of c-Fos led to strong activation of the minimal OPN promoter, whereas no or only moderate activation was observed with ectopically expressed c-Jun, v-Jun, Fra-2, v-Myc, or JunD proteins, respectively.
To directly demonstrate specific interaction of an AP-1 complex containing c-Fos and c-Jun with the proximal AP-1 binding site in the OPN promoter, a doublestranded oligodeoxynucleotide encompassing this motif was used for electrophoretic mobility shift analysis (EMSA). A heterodimer composed of in vitro cotranslated c-Jun/c-Fos proteins was able to bind to this DNA probe with equal specificity compared to a control probe containing the consensus AP-1 site present in the promoter of JAC, a direct Jun target gene (Figure 4a ). The specificity of protein-DNA interactions was demonstrated by competitive inhibition of binding using the unlabeled DNA probe, and by specific interference with binding using antibodies directed against Jun or Fos proteins ( Figure 4a ). As reported previously, Jun or Fos antibodies inhibit DNA binding in the EMSA analysis, rather than inducing supershifts (Suzuki et al., 1994; Hartl et al., 2001) . Antibodies directed against the v-Myc protein or normal rabbit serum did not interfere with DNA binding or induce supershifts (Figure 4a ). Using the OPN-specific DNA probe, significant binding activity was also detected in nuclear extracts prepared from MH2-transformed CEF compared to nuclear extracts derived form normal CEF ( Figure 4b ). As shown for the in vitro translated c-Jun/c-Fos proteins, specificity of binding was demonstrated by unlabeled probe competition and antibody inhibition (Figure 4b) .
To obtain additional evidence that c-Fos/c-Jun complexes bind directly to the OPN promoter, chromatin immunoprecipitation (ChIP) analysis was employed using cross-linked chromatin from CEF/MH2 cells, Fos-and Jun-specific antibodies, and a PCR primer pair for amplification of a 112-bp DNA segment encompassing the proximal AP-1 binding site of the OPN promoter. The PCR analysis specifically produced a 112-bp DNA fragment when Fos-or Jun-specific antibodies were used for the chromatin immunoprecipitation (Figure 4c ). This corroborates the finding that c-Fos and c-Jun bind specifically to the proximal AP-1 motif present in the OPN promoter. As a control, ChIP was performed using chromatin from ASV17-transformed CEF and a primer pair for amplification of a 201-bp segment from the JAC promoter containing the consensus high-affinity AP-1 binding site . The analysis confirmed that v-Jun but not c-Fos binds efficiently to the JAC promoter. Accordingly, the chicken c-Fos protein (p62 c-fos ) activated in MH2-transformed CEF was not detectable in ASV17-transformed cells or in normal CEF (Figure 4d ) demonstrating the specificity of the ChIP data (Figure 4c ) using the Fos-specific antiserum and OPN-specific primers in the case of MH2-transformed cells.
OPN, 126MRP, and Rac2 have intrinsic oncogenic potential and cooperate in cell transformation
To investigate whether the proteins encoded by the three activated target genes are involved in cell transformation, the coding regions of OPN, 126MRP, and rac2 were inserted into replication-competent retroviral vectors (RCAS) and the constructs transfected into avian fibroblasts ( Figure 5 ). To facilitate detection of the protein products by using FLAG antibodies , the FLAG epitope was inserted between the start methionine and the second amino-acid residue of each protein (Figure 5a ). Since the human homologs of both OPN and 126MRP have been implicated in tumorigenesis (Donato, 1999; Denhardt et al., 2001; Marenholz et al., 2004; Moye et al., 2004) , bicistronic retroviral constructs for the simultaneous overexpression of OPN and 126MRP, and also of OPN and rac2, were engineered to test for possible synergistic effects in cell transformation. Protein expression in transfected and metabolically labeled cells was monitored by immunoprecipitation using antibodies directed against the FLAG peptide or against a 220-amino-acid recombinant OPN protein (Figure 5b ). FLAG-126MRP (M r 15 082) and FLAG-Rac2 (M r 22 528) displayed apparent molecular weights of 18 000 and 24 000, respectively. FLAG-OPN (M r of 33 445) migrated with an apparent size of 53 000. A similar anomalous electrophoretic mobility was also observed for the in vitro translated and immunoprecipitated non-tagged full-length OPN (M r 29 335) and the amino terminally truncated recombinant protein OPN220 (M r 24 311) displaying apparent molecular weights of 52 000 and 41 000, respectively (Figure 5b ). The aberrant electrophoretic mobility may be due to the acidic character of OPN proteins (Denhardt et al., 2001 ) (the calculated pI of quail OPN is 4.25). In contrast to the FLAG-OPN protein, the non-tagged OPN protein encoded by the bicistronic FLAG-126MRP-IRES-OPN and FLAGRac2-IRES-OPN constructs was expressed in multiple forms (apparent molecular weights of 52 000, 56 000, 62 000, and 70 000), presumably due to post-translational modification (Srensen et al., 1995) . This is in agreement with previous observations of multiple forms of fowl OPN with sizes ranging from 43 000 to 70 000 under denaturing SDS-PAGE conditions (Castagnola et al., 1991; Kuykindoll et al., 2000) .
Fibroblast cultures fully infected with retroviruses harvested from the transfected cells displayed morphological alterations compared to cells infected with the empty RCAS virus. QEF expressing FLAG-OPN or FLAG-126MRP became slightly more elongated, whereas cells expressing FLAG-Rac2 displayed a more round-shaped morphology. Simultaneous expression of FLAG-126MRP and OPN, or FLAG-Rac2 and OPN led to more pronounced morphological changes of the cells. Control cells transformed by the MH2 virus specifying a v-Myc protein and a Gag-Mil hybrid protein displayed the typical spindle-shaped morphology of v-myc/v-mil-transformed fibroblasts which is clearly distinguishable from the round-shaped morphology of v-myc-transformed cells (Figure 5c , cf. Figure 1a) . Most significantly, CEF expressing 32 P-labeled double-stranded oligodeoxynucleotides (3 nM) derived from the chicken OPN promoter containing the proximal composite non-consensus AP-1 binding motif (5 0 -CCTCATGACCTCA-3 0 ) (AP-1p), or from the chicken JAC promoter containing the consensus AP-1 binding site (5 0 -TGAGTCA-3 0 ) were used as probes (2.5 Â 10 4 cpm) for electrophoretic mobility shift assays (EMSA). The probes in panel a were incubated with equal aliquots from an in vitro transcription/translation reaction using DNA constructs carrying the coding regions for the chicken c-Jun and c-Fos proteins as templates, and the probes in panel b were incubated with 10 mg each of nuclear proteins extracted from normal CEF or from MH2-transformed CEF (CEF/MH2). Incubations were also carried out in the presence of 1-ml aliquots of specific antisera (a) directed against the Jun, Fos, or Myc proteins, of 1 ml of normal rabbit serum (NRS), or of unlabeled AP-1p (OPN) competitor (comp.) DNA (300 nM) as indicated. Protein-DNA complexes were resolved by polyacrylamide (7%, wt/vol) gel electrophoresis. Autoradiography was performed using an intensifying screen (66-h exposure for panel a, 6-h exposure for panel b). The positions of free DNA and of DNA:protein complexes are indicated in the margins. (c) Chromatin-immunoprecipitation (ChIP) analysis of sheared extracts derived from formaldehyde-treated CEF/MH2 or CEF/ASV17 cells. Immunoprecipitations were carried out using Jun-or Fos-specific antibodies followed by PCR amplification of DNA segments encompassing the AP-1 binding sites of the chicken OPN or JAC promoters as described for panel a. Control immunoprecipitations included samples treated with no antibody or with NRS. PCR products were analysed by agarose(1.4%, wt/vol) gel electrophoresis, and visualized by ethidium-bromide staining. The sizes of the PCR products (in bp) are indicated in the margin. (d) Analysis of the c-Fos (p62 c-fos ) protein in normal CEF and in MH2-or ASV17-transformed CEF. Proteins were analysed by immunoprecipitation using a Fos-specific antiserum and SDS-PAGE (10%, wt/vol). The fluorograph was exposed for 5 days. The positions of molecular weight markers (in kDa) are indicated in the margin.
OPN, S100, RAC activation in Myc/Mil(Raf) oncogenesis M Hartl et al FLAG-OPN, FLAG-126MRP, or FLAG-Rac2 formed colonies in soft agar, with OPN and 126MRP displaying the higher capacity of inducing anchorage-independent growth (Figure 5d ). Colony formation by MH2-transformed CEF was used as a control. Simultaneous expression of OPN and FLAG-126MRP led to a significant increase in colony numbers suggesting that these proteins act in a synergistic manner. A similar, but less pronounced effect was observed for the coexpression of OPN and FLAG-Rac2. The results suggest that the activation of OPN, 126MRP and possibly rac2 is involved in v-myc/v-mil-induced cell transformation.
Cooperative cell transformation by the myc and mil oncogenes Analysis of the genome structure of the natural retroviral isolate MH2 had provided strong support to the notion that oncogenes cooperate in cell transformation (Jansen et al., 1983a, b) . This was further supported by the oncogenic spectrum of the retroviral construct J2 combining v-myc and v-mil(raf) oncogenes in a murine vector (Rapp et al., 1985) . To directly demonstrate that the two oncogenes myc and mil cooperate in cell transformation, the coding sequence of v-mil and an internal ribosomal binding site (IRES) were inserted into the replication-defective RCAS-MC29 vector (a) Coding sequences of the OPN, 126MRP, and rac2 genes were inserted into the replication-competent retroviral pRCAS-BP vector via the unique ClaI restriction enzyme site. bla, b-lactamase coding sequence; LTR, long terminal repeat; gag, group-specific antigen; pol, polymerase; env, envelope glycoprotein; kbp, kilobasepairs; FLAG, 8-amino acid epitope; IRES, internal ribosomal entry site. (b) Immunoprecipitation and SDS-PAGE (12%, wt/vol) analysis of OPN, FLAG-OPN, FLAG-126MRP, and FLAG-Rac2 proteins using polyclonal antibodies directed against a 220-amino-acid recombinant OPN polypeptide, or a monoclonal antibody directed against the amino terminal FLAG epitope. Equal aliquots (2 Â 10 7 cpm) of extracts from [ 35 S]methionine-labeled QEF transfected with pRCAS-FLAG-OPN, pRCAS-FLAG-126MRP, pRCAS-FLAG-Rac2, pRCAS-FLAG-126MRP-IRES-OPN, or pRCAS-FLAGRac2-IRES-OPN were analysed. Proteins from in vitro transcription and translation reactions using the plasmid constructs pBS-OPN or pET11d-OPN220 were analysed as a control (lanes 1 and 2). Fluorographs were exposed for 15 h (lanes 1 and 2), 6 days (lane 3), 2 days (lanes 4, 5, 8 and 9), or 10 days (lanes 6 and 7). Positions of protein size markers (in kDa) are indicated in the margin. 4 ) were seeded in soft agar on 35-mm dishes, and bright-field micrographs were taken after 16 days. (Tikhonenko and Linial, 1992) specifying the p110 Gag-Myc hybrid protein (Figure 6a ). The construct (RCAS-MC29-IRES-v-Mil) was co-transfected into QEF together with the replication-competent RCAS vector allowing the generation of infective virus particles. As controls, RCAS-MC29 and RCAS plasmids were co-transfected analogously. Protein analysis of the transfected cells showed that the Gag-Myc and v-Mil proteins were efficiently translated from the bicistronic MC29-IRES-v-Mil mRNA, whereas in RCAS-MC29-transfected cells only the p110 Gag-Myc polypeptide was detectable (Figure 6b ). Both constructs, RCAS-MC29-IRES-v-Mil and RCAS-MC29, significantly enhanced cell proliferation accompanied by characteristic morphological changes in the transfected cells (Figure 6c) , and induced the capacity of anchorageindependent growth (Figure 6d Figure 1a and b) , demonstrating that the oncogenes myc and mil synergistically cooperate in cell transformation.
Discussion
Abnormal cell signaling leads to modified cytoskeletal structures and transcriptome alterations manifested by aberrantly regulated target genes. Several transcription factors positioned at the end of mitogenic signaling casacades have oncogenic potential, and mutant or deregulated forms of such transcriptional regulators are able to induce cancer (Dang, 1999; Grandori et al., 2000; Eisenman, 2001) . A deregulated Ras/Raf(Mil)/MEK/ ERK signaling pathway is involved in many cancer types and leads to the activation of nuclear effectors at the transcriptional or post-transcriptional level, for instance by phosphorylation of critical gene regulators. A prototypic nuclear effector of this signaling cascade is AP-1 (Rapp et al., 1994; Suzuki et al., 1994; Eferl and Wagner, 2003) , but there is also evidence that other transcription factors like Myc could participate in this mitogenic signaling pathway (Kerkhoff and Rapp, 1998 although the molecular mechanisms of Myc activation remain still obscure. There is clear evidence that Myc and Mil(Raf) act synergistically in cell transformation. The strikingly high oncogenic potential of avian leukemia and carcinoma virus MH2 (Bister and Jansen, 1986; Graf et al., 1986) and of its constructed murine counterpart J2 (Rapp et al., 1985) is apparently due to the combination of the v-myc and v-mil(raf) oncogenes in one retroviral genome leading to concomitant highlevel expression of the v-Myc and v-Mil(Raf) oncoproteins. However, v-Myc expression does not lead to increased c-Mil protein levels, and, vice versa, v-Mil does not induce elevated c-Myc levels (cf. Figure 1c) . A possibly complex mechanism of synergism could be based on the acceleration of cell division and proliferation by v-Myc, strongly enhancing the v-Mil(Raf)-induced aberrant mitogenic signaling pathway (Kerkhoff and Rapp, 1998; Grandori et al., 2000) .
To investigate the molecular basis of the strong enhancement of malignancy in the course of v-myc/ v-mil-induced cell transformation and tumorigenesis, we aimed at the isolation of genes that were specifically activated in MH2-transformed cells. Intriguingly, the screen led to the isolation of specifically overexpressed genes that represent the avian homologs of genes previously implicated in human cancer, providing a well-defined experimental cell transformation system to study the function and regulation of these important cancer-related genes. The OPN protein product of the osteopontin gene (OPN) is an acidic hydrophilic glycophosphoprotein that functions both as a cell attachment protein displaying a GRGDS cell adhesion sequence (cf. Figure 2a) and as a cytokine that signals through integrin and CD44 cell adhesion molecules (Denhardt et al., 2001; Rittling and Chambers, 2004) . Originally discovered as a phosphoprotein secreted by transformed cells in culture (Senger et al., 1979) , it is now recognized as a multifunctional protein implicated in development, neoplastic change, tumor progression and metastasis, but is also abundant in the mineral matrix of bones binding tightly to hydroxyl apatite (Mi et al., 2004; Rittling and Chambers, 2004) . OPN not only represents a classical marker for metastatic cells, but has proven intrinsic potential to enhance the metastatic phenotype of tumor cells (Moye et al., 2004; Rittling and Chambers, 2004; Teramoto et al., 2005) . Although there is strong evidence that overexpression of OPN at the mRNA and protein level represents a key molecular event in tumor progression and metastasis, the molecular mechanisms and signaling pathways leading to its transcriptional activation and its precise biochemical function in these disease-related processes are largely unknown (Mi et al., 2004; Rittling and Chambers, 2004) . In this study we have identified OPN as a strongly and specifically activated gene in v-myc/v-mil-transformed cells that also contain markedly elevated levels of the AP-1 components c-Jun and c-Fos (cf. Figure 1) , and we show that activation of the OPN promoter is indeed mediated by binding of AP-1 complexes to a specific site, and that c-Fos may be the principle activating component. Intriguingly, there is strong evidence that Fos proteins are required for malignant progression (Saez et al., 1995) and that they trigger a transcriptional program responsible for cell invasion, a process crucial for morphogenesis and cancer metastasis (Sherwood et al., 2005) . Recently, analyses of murine OPN promoters have also identified AP-1 binding sites as critical elements for transcriptional activation (Bidder et al., 2002; El-Tanani et al., 2004; Mi et al., 2004; Sakata et al., 2004) . Furthermore, it has been suggested that AP-1 is, at least in part, responsible for the overexpression of OPN in human breast cancer (El-Tanani et al., 2004) .
Ectopic expression of OPN from a retroviral vector leads to agar colony formation in primary chicken fibroblasts (cf. Figure 5d) , demonstrating intrinsic oncogenic potential of this gene in a direct cell transformation assay. This extends previous results showing that this gene promotes metastatic potential when introduced into established rat mammary epithelial cell lines (Moye et al., 2004; Teramoto et al., 2005) . The transforming potential of OPN is enhanced by concomitant ectopic expression of the 126MRP gene that is also activated in v-myc/v-mil-transformed cells, suggesting that OPN and 126MRP are able to act in a synergistic manner. The 126MRP protein belongs to the S100 family of small proteins that contain EF-hand calcium-binding domains and are implicated in intracellular and extracellular regulatory activities (Donato, 1999; Marenholz et al., 2004) . Interestingly, both OPN and S100 proteins bind Ca 2 þ , and it has been suggested that calcium-ion binding of phosphorylated OPN influences its conformation in combination with the high density of negative charges around the GRGDS cell-binding sequence (Denhardt et al., 2001) . Free calcium levels may therefore have an impact on the interaction between OPN and its integrin or CD44 receptors (Denhardt et al., 2001; Weber, 2001) . Intriguingly, the human homologs of both OPN and 126MRP are implicated in cell invasion and metastasis. OPN expression, as discussed above, strongly correlates with the metastatic phenotype, and the 126MRP-related S100A4 gene encodes a metastasis-associated cytoskeletal calcium-binding protein, termed metastasin (Marenholz et al., 2004) . Strikingly, in a neu/S100A4 transgenic model of metastatic breast cancer, ectopic expression of S100A4 leads to induction of the 126MRP ortholog S100A9 and of OPN (Simpson et al., 2003) , corroborating our finding that these two genes are implicated in cell transformation.
The highly conserved Rac guanosine triphosphatases are members of the Rho family within the superfamily of Ras-related small GTPases, and play distinct roles in actin organization, cell proliferation, polarity, and migration. Rac signaling is also implicated in invasive and metastatic cell growth (Kurisu et al., 2005) , and it was recently suggested that autocrine activation of an OPN-CD44-Rac pathway in Ras-transformed cells enhances transformation and motility (Teramoto et al., 2005) . Based on the observation that ectopic expression of rac2 leads to agar colony formation in CEF (cf. Figure 5d) , it is conceivable that the Rac2 protein accelerates aberrant autocrine signaling pathways and thus contributes to v-myc/v-mil-induced cell transformation. The results reported here demonstrate that cooperative v-myc/v-mil(raf)-induced cell transformation involves activation of genes and pathways implicated in human cancer progression and metastasis, providing an experimental system for further molecular analyses.
Materials and methods

Cells and retroviruses
Sources of fertile Japanese quail (Coturnix japonica) or chicken (Gallus gallus) eggs, cell culture, DNA transfection, and preparation and transformation of chicken or quail embryo fibroblasts (CEF, QEF) have been described (Hartl and Bister, 1998; Bader et al., 2001; Hartl et al., 2001 Hartl et al., , 2003 . Colony assays performed in 0.3%(wt/vol) agarose were done as described . The established QEF cell lines Q8 and MH2A10 are transformed by the v-myc oncogene of avian acute leukemia virus MC29 , and by the v-myc and v-mil oncogenes of avian acute leukemia virus MH2 (Jansen et al., 1983a) , respectively. Infection of CEF with avian retroviruses was performed as described previously . QEF transformed by the retroviral constructs pRCAS-MC29 (Tikhonenko and Linial, 1992) or pRCAS-v-Jun (pRCAS-VJ1) carrying the v-myc or v-jun oncogenes, respectively have been described (Hartl and Bister, 1998) . For construction of pRCAS-v-Mil, a 1134-bp PCRamplified segment of gag-mil (Sutrave et al., 1984) specifying the last 377 amino acids of v-Mil including the stop codon was inserted into the pA-CLA12NCO adaptor plasmid (Hughes et al., 1987) yielding pA-v-Mil. The v-mil insert was then excised with ClaI and ligated into the replication-competent retroviral pRCAS vector (subgroup A) (Hughes et al., 1987) . For construction of pRCAS-FLAG-OPN, pRCAS-FLAG-126MRP, and pRCAS-FLAG-Rac2, the coding sequences without the start codon but including the stop codon of quail OPN, 126MRP, and rac2 were first ligated into the EcoRV and BamHI sites of the adaptor plasmid pA-FLAG and subsequently transferred into the pRCAS-BP vector as described . To generate pA-FLAG-Rac2-IRES-OPN, the 1127-bp SmaI/PvuII fragment from pA-OPN, consisting of an 1194-bp OPN cDNA EcoRI-fragment ligated into pA-CLA12 (Hughes et al., 1987) , was inserted into pA-FLAGRac2-IRES cut by SmaI. To construct pA-FLAG-Rac2-IRES, the 612-bp NcoI/BamHI(filled in) fragment of pA-FLAGRac2 was ligated into pA-IRES cut by NcoI/EcoRI(filled in). To generate pA-IRES, the 630-bp EcoRI-BamHI fragment of pIRES (BD Biosciences, Vienna, Austria) encompassing the internal ribosome entry site (IRES) of encephalomyocarditis virus (ECMV) (Jackson et al., 1990) was inserted into pA-CLA12NCO. To construct pA-FLAG-126MRP-IRES-OPN, a 1327-bp MluI(filled in)/PvuI fragment from pA-FLAG-Rac2-IRES-OPN containing the FLAG-Rac2 coding sequence was replaced by the corresponding 1097-bp BamHI(filled in)/PvuI fragment from pA-FLAG-126MRP. A 141-bp SacII(blunted)/ SmaI fragment containing the original polyadenylation signal of the OPN cDNA was subsequently removed from pA-FLAG-Rac2-IRES-OPN and from pA-FLAG-126MRP-IRES-OPN. For construction of pRCAS-MC29-IRES-v-Mil, a 1840-bp EcoRI(filled in) fragment containing the IRES element and the coding sequence of v-mil was excised from pIRES-0-v-Mil and ligated into pRCAS-MC29 which has been linearized by KpnI und blunt-ended using the 3 0 -5 0 exonucleolytic activity of T4 DNA polymerase. To construct pIRES-0-v-Mil, the 1224-bp XbaI fragment encompassing the v-mil coding sequence was released from pA-v-Mil and ligated into pIRES cut by XbaI.
Target gene isolation and nucleic-acid analyses cDNA library construction, DNA labelling, plaque hybridization, subcloning, Northern analysis, and nucleotide sequencing were performed as described (Hartl and Bister, 1998; Bader et al., 2001; Hartl et al., 2001 Hartl et al., , 2003 . Subtractive probe generation and representational difference analysis (RDA) were done as described previously Bader et al., 2001) using RNAs isolated from QEF and from MH2A10 cells for generation of driver and tester cDNAs, respectively. For isolation of full-length cDNA clones representing the OPN and 126MRP genes with insert sizes of 1170 and 509 bp, respectively, a MH2A10-specific subtracted probe was used to screen a cDNA library generated from MH2A10 cells. For isolation of a rac2-specific 895-bp full-length clone from the MH2A10 cDNA library, an appropriate RDA fragment was used as a probe. Hybridization probes for Northern analyses included cDNA fragments derived from quail OPN, 126MRP, and rac2 isolated in this screen, and from quail glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as described previously (Hartl and Bister, 1998) . Bioinformatic analyses of nucleotide and amino-acid sequences of the genes identified and sequence interpretation were performed as described (Hartl and Bister, 1998; Bader et al., 2001; Hartl et al., 2001) . To scan the chicken OPN promoter for potential transcription factor binding sites, the computer programs AliBaba2 (Biobase) and TESS (www.cbie.upenn.edu/tess) were applied. For multiple sequence alignments, the program ClustalW (DS/Gene, Accelrys) was used. The nucleotide and deduced amino-acid sequences reported here have been deposited in the GenBank database (accession nos. AF239805, AY583752, AF583754).
Transactivation analysis
For construction of the chloramphenicol acetyltransferase (CAT) reporter plasmid pCAT-OPN, a 1242-bp DNA fragment encompassing the chicken OPN promoter including 86 bp of the first exon was amplified from chicken genomic DNA by PCR and then inserted into the SphI/SalI sites of the pCAT-Basic vector (Promega, Mannheim, Germany). This OPN promoter segment corresponds to nucleotides 16015255-16014014 of contig 6 (accession number NW_060347.1) from chicken chromosome 4. To construct the deletion mutants pCAT-OPN348, pCAT-OPN197, pCAT-OPN96, the OPN promoter was progressively deleted using PstI, DpnI, or HaeIII restriction enzyme sites leaving 348, 197, or 96 bp promoter segments upstream of the transcription start site which has been mapped previously (Rafidi et al., 1994) . Site-directed deletion mutagenesis was performed as described ) using pCAT-OPN, pCAT-OPN197, or pCAT-OPN96 as templates, and mutator oligodeoxynucleotides leading to deletion of the sequences 5 0 -TGACTCC-3 0 (pCAT-OPNDAP1d), 5 0 -TCATGACCTCA-3 0 (pCAT-OPN DAP1p, pCAT-OPN197DAP1p, pCAT-OPN96DAP1p), or 5 0 -TTTAAATCCC-3 0 (pCAT-OPN197DTATA) that contain distal (d) or proximal (p) AP-1 binding motifs, or the TATA -box, respectively. The double mutant pCAT-OPN197 DAP1pDTATA was constructed using pCAT-OPN197DTA TA as a template. The eukaryotic expression vectors pRc-cJun, pRc-JunD, pRc-v-Jun, pRc-c-Fos, pRc-Fra-2, pRcv-Myc have been described (Hartl et al., , 2003 . DNA transfer into cells by the nucleofection technology (Axama Biosystems, Cologne, Germany) was performed as described (Hartl et al., 2003) . For all nucleofections, liposome solution V was applied in combination with the electroporation program T-20. CAT-analysis and quantification of radioactive signals using a phosphor imager were performed as described (Hartl et al., , 2003 .
Protein-DNA interaction analyses
In vitro translation of proteins, preparation of nuclear extracts from subconfluently grown cells, and electrophoretic mobility shift assays (EMSA) were carried out as described (Hartl and Bister, 1998; Hartl et al., 2001) . A 32 P-labeled 51-bp doublestranded oligodeoxynucleotide corresponding to nucleotide positions À110 to À60 upstream of the OPN transcription start site and containing the two overlapping non-consensus AP-1 binding motifs was prepared as described (Hartl and Bister, 1998) . The DNA probe encompassing the consensus AP-1 binding site from the chicken JAC promoter has been described previously . Binding reactions were performed at 251C in a buffer containing 10 mM HEPES pH 7.9, 5 mM MgCl 2 , 0.1 mM EDTA, 20 mM NaCl, 10%(vol/ vol) glycerol, 2 mM DTT, 2 mM spermidine (for in vitro translated proteins), or a buffer containing 12 mM HEPES pH 7.9, 4 mM Tris-HCl pH 7.9, 60 mM KCl, 12%(vol/vol) glycerol, 1 mM EDTA, 1 mM DTT (for nuclear extract proteins), each supplemented with 133 ng/ml of poly(dIdC) Á poly(dI-dC). To test for binding specificity, 1-ml aliquots of polyclonal antisera directed against Jun, Fos, or Myc proteins were added 30 min after the binding reaction was initiated, and incubation was continued for another 15 min.
Chromatin immunoprecipitation analysis (ChIP) was carried out as described previously (Chamboredon et al., 2003) with the following modifications. Samples of 2.5 Â 10 7 cells grown on 100-mm dishes were cross-linked with formaldehyde (final concentration 1%). The washed and pelleted material was then resuspended in 1 ml of SDS-lysis buffer containing 1%(wt/vol) sodium dodecyl sulfate (SDS), 10 mM EDTA, 50 mM Tris-HCl pH 8.1 supplemented with protease inhibitors. Chromosomal DNA was sheared to yield fragments with sizes between 0.2 and 1.0 kbp using an ultrasonifier (Branson, Danbury, CT, USA) equipped with a microtip at constant 40 W (25% power) for 6 Â 10 s. Sonicated lysates were centrifuged, and the supernatant was diluted ten-fold with ChIP dilution buffer containing 0.01%(wt/vol) SDS, 1.1%(wt/ vol) Triton s X-100 (Merck), 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, and 167 mM NaCl. For immunoprecipitation, 1 ml of this solution was precleared by adding 80 ml of a 50%(wt/vol) protein A sepharose CL-4B (Amersham Biosciences, Vienna, Austria) bead slurry supplemented with 0.2 mg/ml sonicated salmon sperm DNA and 0.5 mg/ml BSA, and gentle shaking for 60 min at 41C. The beads were pelleted, and the supernatant was incubated with 2 ml of specific antiserum at 41C for 16 h. Protein A sepharose slurry was added and samples processed as above. The pellets were washed twice with washing buffer 1 (0.5% sodium deoxycholate, 1% Nonidet P40, 50 mM TrisHCl pH 7.5, 150 mM NaCl), once with washing buffer 2 (0.05% sodium deoxycholate, 0.1% Nonidet P40, 50 mM TrisHCl pH 7.5, 500 mM NaCl), once with washing buffer 3 (0.05% sodium deoxycholate, 0.1% Nonidet P40, 50 mM TrisHCl pH 7.5), and finally twice with TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA). Immunoprecipitated cross-linked protein-DNA complexes were incubated for 30 min at 251C in 450 ml of elution buffer containing 1% SDS and 100 mM NaHCO 3 . NaCl was then added to a final concentration of 192 mM and incubation was continued at 651C for 4 h. As a control, a 450-ml input sample containing 40 ml of sonicated and diluted cell lysate and 410 ml of elution buffer was treated analogously. Then, EDTA, Tris-HCl pH 6.5, and proteinase K were added to final concentrations of 9.4, 36 mM, and 3.6 mg/ ml, respectively, and incubation was continued for 1 h at 451C. DNA was recovered by phenol/chloroform extraction and ethanol precipitation. Thirty-three PCR cycles (941C/1 min; 541C (OPN), 561C (JAC)/1 min; 721C/1 min) were carried out using 20% each of the recovered DNAs with primers flanking functional AP-1 binding sites present in the OPN or JAC promoters. The OPN-and JAC-specific PCR primer pairs were 5 0 -CTTCAGAAGCCACAAAGC-3 0 / 5 0 -GAGAGCAGCCACCAATCC-3 0 and 5 0 -ATCCTATCT GGTAAAACACC-3 0 /5 0 -TGAATTTGTCCTCACTGC-3 0 , respectively.
Recombinant protein purification and antiserum generation OPN-specific antiserum was generated using a purified recombinant polypeptide as immunogen containing the carboxyl terminal 219 amino acids of quail OPN and a vector-encoded start methionine (OPN220). For construction of pET11d-OPN220, a PCR fragment encompassing the coding region for amino-acid residues 46-264 and the stop codon was ligated into the bacterial expression vector pET-11 d (Novagen, Vienna, Austria). Transformation of Escherichia coli BL21(DE3)pLysS with pET11d-OPN220, and induction of recombinant protein synthesis using isopropylb-D-thiogalactoside (IPTG) to a final concentration of 1.0 mM were performed as described (Kerkhoff et al., 1991; Hartl and Bister, 1998; Bader et al., 2001) . Cells were pelleted and resuspended in 30 ml of ice-cold lysis buffer (50 mM Tris-HCl pH 8.0, 2 mM EDTA) per liter of the original bacterial culture, and lysed by a freeze-thaw cycle. DNA was sheared by passing the lysate through a 20 G needle. After centrifugation at 26 000 g for 30 min, the supernatant was fractionated by ammonium sulfate precipitation. The precipitate formed between 40 and 50% saturation was dissolved and dialyzed at 41C in phosphate-buffered saline (PBS) containing 1 mM DTT, and then loaded onto a FPLC MonoQ anion exchange column (Amersham Biosciences, Vienna, Austria). Proteins were eluted with a sodium chloride gradient generated by mixing PBS (150 mM NaCl) and high salt PBS (1 M NaCl). Fractions containing OPN220 were concentrated using a Centriprep-10 ultrafiltration device (Amicon, Vienna, Austria), and the protein was further purified using a Superdex-75 gelfiltration column (Amersham Biosciences, Vienna, Austria). The final yield of purifed OPN220 protein was 3.6 mg per liter of bacterial culture. Immunization and antiserum preparation were done as described (Hartl and Bister, 1998; Bader et al., 2001) . Polyclonal antisera directed against recombinant Jun, Fos, or Myc proteins, or against a carboxyl terminal Mil undecapeptide, and a monoclonal antibody directed against the FLAG epitope have been described (Hartl and Bister, 1998; Patschinsky and Bister, 1988; Hartl et al., 2001) .
Protein analysis
To construct pBS-OPN, the ClaI insert of pA-OPN containing the coding region of OPN (see above) was inserted into pBluescript II SK( þ ) (Stratagene, La Jolla, CA, USA). pBS-OPN and pET11d-OPN220 specifying the truncated OPN protein (see above) were used for in vitro transcriptiontranslation. Immunoprecipitations under denaturing conditions of L-[ 35 S]methionine-labeled proteins from cell lysates or supernatants, or from in vitro transcription-translation reactions using polyclonal or monoclonal antibodies, and SDS-PAGE were done as described (Hartl and Bister, 1998; Hartl et al., 2001 Hartl et al., , 2003 .
